BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18500519)

  • 1. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
    Niscola P; Palumbo R; Scaramucci L; Tendas A; Cupelli L; Giovannini M; Piccioni D; Dentamaro T; Perrotti AP; de Fabritiis P
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Bennett M; Yegena S; Dave HP; Schechter GP
    Hematol Oncol; 2008 Jun; 26(2):114. PubMed ID: 18271062
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful rituximab monotherapy for API2-MALT1 fusion positive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis.
    Yamada M; Kawahara H; Shiroeda H; Tsuchishima M; Masaki Y; Sato K; Takase S
    Scand J Gastroenterol; 2008; 43(6):761-4. PubMed ID: 18569996
    [No Abstract]   [Full Text] [Related]  

  • 4. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.
    Harner KC; Jackson LW; Drabick JJ
    Rheumatology (Oxford); 2004 Oct; 43(10):1309-10. PubMed ID: 15448217
    [No Abstract]   [Full Text] [Related]  

  • 5. Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.
    Seker M; Ustaalioğlu BB; Bilici A; Yildirim ME; Kefeli U; Barisik NO; Tamer I; Gumus M
    Leuk Res; 2010 Jul; 34(7):e160-3. PubMed ID: 20219245
    [No Abstract]   [Full Text] [Related]  

  • 6. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
    Kalpadakis C; Pangalis GA; Sachanas S; Rontogianni D; Korkolopoulou P; Milionis V; Vassilakopoulos TP; Papadaki HA; Angelopoulou MK
    Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature.
    Naymagon L; Ward S; Naymagon S; Navada S
    Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):e165-e168. PubMed ID: 30685184
    [No Abstract]   [Full Text] [Related]  

  • 10. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.
    Dungarwalla M; Appiah-Cubi S; Kulkarni S; Saso R; Wotherspoon A; Osuji N; Swansbury J; Cunningham DC; Catovsky D; Dearden CE; Matutes E
    Br J Haematol; 2008 Oct; 143(1):71-4. PubMed ID: 18671706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment with rituximab in a patient with splenic marginal zone B-cell lymphoma accompanied by cold agglutinin disease].
    Yasuyama M; Kawauchi K; Otsuka K; Tamura H; Fujibayashi M
    Nihon Ronen Igakkai Zasshi; 2014; 51(6):569-75. PubMed ID: 25749330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.
    Komeno Y; Shibuya N; Uryu H; Yamada H; Toda T; Shibasaki M; Kunishima S; Iihara K; Ryu T
    Intern Med; 2017; 56(5):557-562. PubMed ID: 28250305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report.
    Arcaini L; Sacchi P; Jemos V; Lucioni M; Rumi E; Dionigi P; Paulli M
    Ann Hematol; 2009 Apr; 88(4):379-81. PubMed ID: 18709501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
    Fujita T; Asagoe K; Sakoda H
    Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary MALT lymphoma with macroglobulinemia].
    Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Feb; 46(2):144-6. PubMed ID: 16447709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
    Schaefer IM; Marx A; Sauer C; Hohloch K; Ghadimi BM; Trümper L; Ströbel P
    Histopathology; 2013 Mar; 62(4):664-7. PubMed ID: 23379885
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
    Manner H; Jung B; Tonassi L; Hackenberg U; Plum N; Josten KM; Kirchmaier CM; Frickhofen N
    Am J Med Sci; 2008 May; 335(5):394-7. PubMed ID: 18480659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up.
    Cervetti G; Galimberti S; Pelosini M; Ghio F; Cecconi N; Petrini M
    Ann Oncol; 2013 Sep; 24(9):2434-8. PubMed ID: 23712547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes.
    Iannitto E; Minardi V; Calvaruso G; Ammatuna E; Florena AM; Mulè A; Tripodo C; Quintini G; Abbadessa V
    Eur J Haematol; 2005 Aug; 75(2):130-5. PubMed ID: 16000129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.